Home Equities Score 9 Meters Biopharma, Inc. (NMTR) stock falls in Pre-Market: Why is it...

9 Meters Biopharma, Inc. (NMTR) stock falls in Pre-Market: Why is it so?

9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage biopharmaceutical company specializing in treatments for rare diseases with unmet medical attention. , announced that the Company’s Chief Executive Officer, John Temperato will report a corporate update at Oppenheimer’s Rare & Orphan Disease Summit. NMTR stock price declined adjacent to the news.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check-in premarket trading, shares of 9 Meters Biopharma Inc. (NMTR) were down -5.04% at $1.13. NMTR’s stock closed the last session at $1.19, increasing 3.48% or $0.04. Shares of the company fluctuated between $1.13 and $1.21 throughout the day. The shares of 9 Meters Biopharma Inc. have advanced 8.18% in the last five days; however, they have gained 12.26% over the last month.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

9 Meters Biopharma, Inc. Receives USAN Approval

United States Adopted Names (USAN) Council has formally appointed NMTR’s long-term injection administered glucagon-like peptide-1 receptor agonist drug candidate for short bowel syndrome, NM-002, as ‘vurolenatide’

Vurolenatide, a unique chemical, is a long-lasting injectable glucagon-like peptide-1 (GLP-1) receptor agonist that makes use of proprietary XTEN technology to substantially increase its half-life in the human bloodstream. Vurolenatide has been shown to significantly enhance gastric motility in several after-surgery phenotypes of short bowel syndrome (SBS) patients by steadily digestive transit period.

This mechanism is also used to enhance intestinal absorption of nutrients and water and diminish diarrhea for people affected with SBSirrespective of parenteral support requirements.

The ending months of 2020 depicted positive statistics from its Phase 1b/2a study in adult patients affected with short bowel syndrome, with NMTR objective to start the largest placebo-controlled Phase 2 trial in SBS in a regulated setting in the second quarter of 2021, which will be inclusive of patients with all after-surgery phenotypes of SBS.

An FDA meeting communication conducted in the first quarter of 2021 supports using total stool output (TSO) as the main efficacy result measured in the Company’s planned vurolenatide Phase 2 study.

The rate of incidence of short bowel syndrome is anticipated at approximately 5 to 10 patients per million people per annum. In adults, the incidence of SBS which needs at-home parenteral nutrition is approximately two adult patients per million people per annum.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Positive topline data for treatment of SBS has been a positive milestone for NMTR however, having an extremely low rate of incidence combined with reduced investor expectation for the corporate update has investors skeptical about company economic feasibility with NMTR stock price declining at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

Arrival Inc. (ARVL) stock falls during pre-market trading. Here’s what you should know?

Arrival Inc. (NASDAQ: ARVL) stock plunged by 4.96% at last close while the ARVL stock price declines by 9.68% in the pre-market trading session....

Why Zomedica Corp. (ZOM) stock jumped on Thursday?

Zomedica Corp. (ZOM) shares were climbed 4.04% in after-hours on Thursday, June 17, 2021, and close the day at $0.94 per share. Earlier, ZOM's...

Novan Inc. (NOVN) stock plunged during pre-market. Let’s find out why?

Novan Inc. (NASDAQ: NOVN) stock declined by 9.36% at last close while the NOVN stock price plunged by 18.77% in the pre-market trading. Novan...

Why Toughbuilt Industries Inc (TBLT) stock went up on Wednesday?

Toughbuilt Industries Inc (TBLT) stock jumped 12.35% in the after-market on Wednesday, June 16, 2021, and close at $0.96 per share. Earlier in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam